Niraparib in Japanese Patients with Heavily Pretreated, Homologous Recombination-Deficient Ovarian Cancer: Final Results of a Multicenter Phase 2 Study.
Journal of Gynecologic Oncology(2024)
Key words
Clinical Trial,Phase II,Poly(ADP-ribose) Polymerase Inhibitors,Ovarian Cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined